Glenmede Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.9M | Sell |
1,135,862
-1,391
| -0.1% | -$81.1K | 0.34% | 65 |
|
|
2025
Q4 | $61.3M | Buy |
+1,137,253
| New | +$54.7M | 0.29% | 75 |
|
|
2025
Q1 | $63.6M | Buy |
1,042,096
+11,148
| +1% | +$650K | 0.34% | 70 |
|
|
2024
Q4 | $58.3M | Buy |
1,030,948
+87,677
| +9% | +$4.9M | 0.3% | 79 |
|
|
2024
Q3 | $48.8M | Sell |
943,271
-296,440
| -24% | -$13.9M | 0.23% | 90 |
|
|
2024
Q2 | $51.5M | Sell |
1,239,711
-133,064
| -10% | -$5.95M | 0.26% | 86 |
|
|
2024
Q1 | $74.4M | Sell |
1,372,775
-35,413
| -3% | -$1.8M | 0.37% | 66 |
|
|
2023
Q4 | $72.3M | Buy |
1,408,188
+164,182
| +13% | +$8.62M | 0.37% | 66 |
|
|
2023
Q3 | $72.2M | Sell |
1,244,006
-362,524
| -23% | -$22.2M | 0.41% | 57 |
|
|
2023
Q2 | $111M | Sell |
1,606,530
-448
| -0% | -$30K | 0.63% | 32 |
|
|
2023
Q1 | $111M | Buy |
1,606,978
+10,824
| +0.7% | +$763K | 0.63% | 32 |
|
|
2022
Q4 | $115M | Sell |
1,596,154
-16,143
| -1% | -$1.22M | 0.67% | 28 |
|
|
2022
Q3 | $115M | Buy |
1,612,297
+8,478
| +0.5% | +$615K | 0.72% | 25 |
|
|
2022
Q2 | $123M | Buy |
1,603,819
+169,230
| +12% | +$12.9M | 0.72% | 25 |
|
|
2022
Q1 | $105M | Sell |
1,434,589
-4,039
| -0.3% | -$271K | 0.51% | 40 |
|
|
2021
Q4 | $89.7M | Sell |
1,438,628
-55,311
| -4% | -$3.24M | 0.43% | 53 |
|
|
2021
Q3 | $88.4M | Sell |
1,493,939
-16,195
| -1% | -$1.07M | 0.46% | 48 |
|
|
2021
Q2 | $101M | Sell |
1,510,134
-67,515
| -4% | -$4.4M | 0.52% | 41 |
|
|
2021
Q1 | $99.6M | Sell |
1,577,649
-72,528
| -4% | -$4.51M | 0.54% | 39 |
|
|
2020
Q4 | $102M | Sell |
1,650,177
-2,045
| -0.1% | -$126K | 0.56% | 36 |
|
|
2020
Q3 | $99.6M | Sell |
1,652,222
-9,565
| -0.6% | -$576K | 0.6% | 38 |
|
|
2020
Q2 | $97.7M | Sell |
1,661,787
-1,825,581
| -52% | -$109M | 0.6% | 41 |
|
|
2020
Q1 | $224M | Hold |
3,487,368
| – | – | 1.02% | 6 |
|
|
2019
Q4 | $224M | Buy |
3,487,368
+1,560,071
| +81% | +$89.3M | 1.02% | 6 |
|
|
2019
Q3 | $97.7K | Buy |
1,927,297
+217,842
| +13% | +$10.2M | 0.45% | 53 |
|
|
2019
Q2 | $77.5K | Buy |
1,709,455
+278,728
| +19% | +$13M | 0.34% | 70 |
|
|
2019
Q1 | $68.3K | Buy |
1,430,727
+775,266
| +118% | +$38.6M | 0.31% | 83 |
|
|
2018
Q4 | $34.1K | Buy |
655,461
+92,873
| +17% | +$4.99M | 0.17% | 175 |
|
|
2018
Q3 | $34.9M | Buy |
562,588
+98,436
| +21% | +$5.84M | 0.14% | 236 |
|
|
2018
Q2 | $25.7M | Buy |
464,152
+18,429
| +4% | +$995K | 0.11% | 260 |
|
|
2018
Q1 | $27.3M | Hold |
445,723
| – | – | 0.11% | 258 |
|
|
2017
Q4 | $27.3M | Buy |
445,723
+44,579
| +11% | +$2.79M | 0.11% | 258 |
|
|
2017
Q3 | $25.6M | Buy |
401,144
+54,180
| +16% | +$3.16M | 0.11% | 262 |
|
|
2017
Q2 | $18.9M | Hold |
346,964
| – | – | 0.09% | 299 |
|
|
2017
Q1 | $18.9M | Sell |
346,964
-4,871
| -1% | -$267K | 0.09% | 299 |
|
|
2016
Q4 | $20.6M | Sell |
351,835
-9,592
| -3% | -$524K | 0.11% | 285 |
|
|
2016
Q3 | $19.5M | Sell |
361,427
-8,115
| -2% | -$521K | 0.11% | 285 |
|
|
2016
Q2 | $27.2M | Sell |
369,542
-527
| -0.1% | -$37.2K | 0.16% | 216 |
|
|
2016
Q1 | $23.6M | Sell |
370,069
-23,207
| -6% | -$1.46M | 0.15% | 232 |
|
|
2015
Q4 | $27.1M | Buy |
393,276
+4,264
| +1% | +$282K | 0.18% | 172 |
|
|
2015
Q3 | $23M | Buy |
389,012
+1,672
| +0.4% | +$106K | 0.17% | 200 |
|
|
2015
Q2 | $25.8M | Sell |
387,340
-34,665
| -8% | -$2.28M | 0.19% | 173 |
|
|
2015
Q1 | $27.2M | Buy |
422,005
+4,559
| +1% | +$285K | 0.2% | 156 |
|
|
2014
Q4 | $24.6M | Buy |
417,446
+10,734
| +3% | +$605K | 0.19% | 155 |
|
|
2014
Q3 | $20.8M | Sell |
406,712
-30,186
| -7% | -$1.51M | 0.18% | 167 |
|
|
2014
Q2 | $21.2M | Buy |
436,898
+779
| +0.2% | +$38.4K | 0.19% | 141 |
|
|
2014
Q1 | $22.7M | Sell |
436,119
-13,637
| -3% | -$726K | 0.21% | 111 |
|
|
2013
Q4 | $23.9M | Buy |
449,756
+64,902
| +17% | +$3.31M | 0.24% | 90 |
|
|
2013
Q3 | $17.8M | Sell |
384,854
-2,659
| -0.7% | -$117K | 0.21% | 108 |
|
|
2013
Q2 | $17.3M | Buy |
+387,513
| New | +$16.8M | 0.22% | 98 |
|
Other funds holding BMY
VCM
VPM
Glenmede Trust's BMY Position: Q1 2026 in Review
Glenmede Trust reduced its Bristol-Myers Squibb (BMY) stake by 0.12% in Q1 2026, selling an estimated $81.1K and leaving 1,135,862 shares worth $68.9M. The position accounts for 0.34% of the portfolio, ranked #65.
Glenmede Trust first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $224M in Q1 2020. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Glenmede Trust held 1,135,862 shares of Bristol-Myers Squibb worth $68.9M as of Q1 2026.
- Glenmede Trust sold 1,391 Bristol-Myers Squibb shares in Q1 2026, an estimated $81.1K.
- Bristol-Myers Squibb made up 0.34% of Glenmede Trust's portfolio in Q1 2026, its #65 holding.
- Glenmede Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's Bristol-Myers Squibb position peaked at $224M in Q1 2020.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.